Katz-Greenberg Goni, Afshar Yalda, Bonn Julie, Casale Jillian, Constantinescu Serban, DeFilippis Ersilia M, George Roshan P, Iltis Ana, Jesudason Shilpanjali, Kittleson Michelle, Levine Deborah J, Moritz Michael J, Sarkar Monika, Shah Silvi, Uccellini Kimberly, Coscia Lisa A, Rossi Ana P
Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, NC.
Division of Maternal Fetal Medicine, University of California Los Angeles, Los Angeles, CA.
Transplantation. 2025 Sep 1;109(9):1483-1494. doi: 10.1097/TP.0000000000005341. Epub 2025 Mar 13.
Solid organ transplantation (SOT) offers people with end-stage organ disease an increased quality of life, which includes the return of fertility and the potential for pregnancy. Although the number of pregnancies has increased, definitive recommendations have been lacking. To address reproductive health in SOT recipients, the American Society of Transplantation Women's Health Community of Practice held a virtual Controversies Conference with subject matter experts gathered to discuss topics of contraception, immunosuppression, and pregnancy in SOT recipients and pregnancy post-living donation. This publication is a synthesis of expert guidance and available data regarding pregnancy management and outcomes after all types of SOTs.
实体器官移植(SOT)为终末期器官疾病患者提供了更高的生活质量,其中包括生育能力的恢复和怀孕的可能性。尽管怀孕的人数有所增加,但一直缺乏明确的建议。为了解决实体器官移植受者的生殖健康问题,美国移植学会女性健康实践社区举办了一次虚拟争议会议,召集了相关主题专家,讨论实体器官移植受者的避孕、免疫抑制、怀孕以及活体捐赠后的怀孕等话题。本出版物综合了关于各类实体器官移植后妊娠管理及结局的专家指导意见和现有数据。